Get unlimited access to our best features
Subscribe now

SNS saved over 292 million in six years with biosimilar drugs

Summary by Publico
At stake are generics of biological drugs that are used to treat various diseases such as cancer and autoimmune diseases. The access to more information and the existence of rules by entities of the Ministry of Health can lead to an increase in its use, concludes a study by the National School of Public Health.
1 month ago·Lisbon, Portugal

News Articles

More Filters
All
Left
Center
Right
Publico

SNS saved over 292 million in six years with biosimilar drugs

At stake are generics of biological drugs that are used to treat various diseases such as cancer and autoimmune diseases. The access to more information and the existence of rules by entities of the Ministry of Health can lead to an increase in its use, concludes a study by the National School of Public Health.

1 month ago·Portugal
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

No sources with tracked biases.
Untracked bias
See less detail